Proceedings of the American Thoracic Society Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Proceedings of the American Thoracic Society 5:311-315 (2008)
© 2008 The American Thoracic Society
doi: 10.1513/pats.200710-159DR

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Laurent, G. J.
Right arrow Articles by Chambers, R.
PubMed
Right arrow Articles by Laurent, G. J.
Right arrow Articles by Chambers, R.

Escape from the Matrix

Multiple Mechanisms for Fibroblast Activation in Pulmonary Fibrosis

Geoffrey J. Laurent1, Robin J. McAnulty1, Michael Hill1 and Rachel Chambers1

1 Centre for Respiratory Research, Rayne Institute, Royal Free and University College Medical School, London, United Kingdom

Correspondence and requests for reprints should be addressed to Geoffrey J. Laurent, Ph.D., F.R.C.Path., F.Med.Sci., Centre for Respiratory Research, Rayne Institute, Royal Free & University College Medical School, 5 University Street, London WC1E 6JJ, UK. E-mail: g.laurent{at}ucl.ac.uk

ABSTRACT

Lung fibrosis is a recognized feature of many chronic lung diseases and is central to the pathogenesis of idiopathic pulmonary fibrosis, a disease that carries a prognosis worse than many cancers. Current research into this condition is defining the key pathways of activation either in resident fibroblasts, matrix-producing cells derived from circulating fibrocytes, or epithelial cells that appear to transdifferentiate to fibroblast-like cells. The downstream signaling pathways are also being delineated as well as the gene interactions leading to altered cell phenotype. These studies have led to an appreciation that multiple pathways, including inflammatory and coagulation cascades, are involved in the pathogenesis of idiopathic pulmonary fibrosis. As these facts come to light, we are exploring promising new approaches to treat fibroses and halt the inexorable progression that is a feature of these disorders. This article reviews these findings and our current concepts of the key molecular events leading to tissue damage and excessive matrix deposition in lung fibrosis. It also highlights the need for new studies to delineate alternative pathogenetic mechanisms and integrate these pathways so we have a framework to better understand their importance in individual patients.

Key Words: fibroblasts • lung fibrosis • matrix







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Thoracic Society.